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Abstract
Background: Cellular clearance of reactive oxygen species is dependent on a network of tightly coupled redox
enzymes; this network rapidly adapts to oxidative conditions such as aging, viral entry, or inflammation. Current
widespread use of shRNA as a means to perturb specific redox couples may be misinterpreted if the targeted
effects are not monitored in the context of potential global remodeling of the redox enzyme network.
Results: Stable cell lines containing shRNA targets for glutaredoxin 1, thioredoxin 1, or glucose-6-phosphate
dehydrogenase were generated in order to examine the changes in expression associated with altering cytosolic
redox couples. A qRT PCR array revealed systemic off-target effects of altered antioxidant capacity and reactive
oxygen species formation. Empty lentiviral particles generated numerous enzyme expression changes in
comparison to uninfected cells, indicating an alteration in antioxidant capacity irrespective of a shRNA target. Of
the three redox couples perturbed, glutaredoxin 1, attenuation produced the most numerous off-target effects
with 10/28 genes assayed showing statistically significant changes. A multivariate analysis extracted strong co-
variance between glutaredoxin 1 and peroxiredoxin 2 which was subsequently experimentally verified.
Computational modeling of the peroxide clearance dynamics associated with the remodeling of the redox network
indicated that the compromised antioxidant capacity compared across the knockdown cell lines was unequally
affected by the changes in expression of off-target proteins.
Conclusions: Our results suggest that targeted reduction of redox enzyme expression leads to widespread
changes in off-target protein expression, changes that are well-insulated between sub-cellular compartments, but
compensatory in both the production of and protection against intracellular reactive oxygen species. Our
observations suggest that the use of lentivirus can in itself have off-target effects on dynamic responses to
oxidative stress due to the changes in species concentrations.
Background
The cellular redox environment is determined by
numerous electron couples, including glutathione/glu-
tathione disulfide (GSH/GSSG), reduced thioredoxin/
oxidized thioredoxin, NAD(P)H/NAD(P)
+, and cysteine/
cystine, that transfer electrons during changes in intra-
cellular oxidation state. These redox couples are in turn
maintained out of equilibrium by a network of
biochemical reactions, connected through a common set
of substrates, products and co-factors. The overall beha-
vior of this system is regarded as the antioxidant capa-
city of the cell and it determines the rate of reactive
oxygen species (ROS) clearance from the cellular envir-
onment. In prior work, we have quantitatively described
through computational modeling the collective proper-
ties of the redox enzymatic network as it pertains to
exogenous hydrogen peroxide clearance from the cytosol
and protein thiol oxidation/reduction [1]. This computa-
tional analysis demonstrated the relative contributions of
peroxiredoxins, glutathione peroxidase, catalase, and
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hydrogen peroxide from the intracellular environment.
This model was specific to the Jurkat T-lymphocyte cell
line, yet through the adjustment of initial enzyme, glu-
tathione, and NAD(P)H concentrations this model could
in principle simulate the oxidative protection mechan-
isms of other cell types.
Cellular variability in redox potentials is well-docu-
mented; for example, resting glutathione potential can
range from -200 mV to -260 mV depending on cell type
and culture conditions [2]. Furthermore, sensitivity of
the cellular redox potential to cell cycle [3-5], viral load
[6-10], and remodeling during inflammation [11,12]
indicate that the set points of redox couples are readily
altered by the “malleability” of redox enzyme gene
expression. Numerous studies have examined the cDNA
changes that occur across the genome in response to
alterations in the oxidative environment (e.g. HIV infec-
tion, hypoxia, age); however these studies primarily
report the significant up- or down-regulated gene hits
from the conditions assayed without consideration of
the subtle changes that could occur across the redox
network.
Given that the expression levels of redox enzymes are
readily altered, we asked whether targeted perturbation
of specific redox couples would result in global remodel-
ing of the redox enzyme network. RNA interference has
become a common tool for biologists to quickly reduce
protein levels in order to explore gene function with
greater specificity than small molecule inhibitors can
provide. Non-overlapping sequences of short hairpin
RNA (shRNA) which have variable efficiency of interfer-
ence can be exploited to generate “epi-allelic” cell lines
with a range of protein silencing [13,14]. As RNAi is uti-
lized with greater frequency to investigate the role of
oxidative protein thiol modifications in cellular function
[15-22], it is important to consider the specificity of
RNAi perturbations with respect to intracellular oxidant
sources and sinks. The introduction of viral particles
induces oxidative stress and can alter cellular antioxi-
dant levels; this alteration of cellular protein levels
[23,24] may have unexpected redox-related conse-
quences beyond potential off-target silencing, conse-
quences that may substantially alter the redox capacity
of the knockdown cells.
In order to discern changes in the redox environment
that are primarily due to the on-target effects of viral
incorporation as opposed to the off-target remodeling
effects of redox couple perturbations, we performed a
systematic analysis of the changes in expression of 28
redox-related genes due to stable RNAi knockdown of
glutaredoxin 1 (Grx1), thioredoxin 1 (Trx1), or glucose-
6-phosphate dehydrogenase (G6PD). We used computa-
tional programming to compare the redox ramifications
of non-specific mRNA alterations to the redox ramifica-
tions of the idealized targeted knockdown scenarios.
The dynamic analysis of intracellular hydrogen peroxide
clearance indicates that surprisingly, while perturbing
Trx1, Grx1, and G6PD have large consequences on anti-
oxidant capacity, additional non-specific effects likely
only modify the redox capacity of Grx1 shRNA trans-
duced cells.
Results
Knockdown creation and validation
Lentiviral particles containing unique, non-overlapping
mRNA sequences for each gene were used to generate
shRNA-silenced Jurkat cell lines targeting Grx1, Trx1,
and G6PD. Stable cell lines were created for each
shRNA by puromycin selection. The most efficient
shRNA for each gene of interest showed greater than
50% perturbation of mRNA levels as measured by qRT
PCR (Figure 1A) and protein levels were further con-
firmed by western blot (Figure 1B). The fold changes in
Grx1, Trx1, and G6PD levels were normalized relative
to a housekeeping gene, b-actin, and compared to
mRNA levels in the empty lentivirus (pLKO.1-puro)
cells. The stable knockdown cell lines showed phenoty-
pic differences in their growth rates (Figure 1C), with
the Trx1 shRNA cells doubling at a slower pace than
the other lines.
Variability of non-target redox enzymes
We designed a PCR array consisting of 28 gene targets
(Table 1) to examine the systematic variability of other
non-targeted redox enzymes in the presence of shRNA
lentiparticles. The genes selected for analysis were cho-
sen to provide further insight into effects of lentiviral
introduction on proteins that coordinate H2O2 produc-
tion, transport, and clearance from the intracellular
environment. We first compared wild-type Jurkat cells
to cells that had been stably transduced with empty len-
tivirus (pLKO.1-puro) and observed significant changes
in cellular mRNA levels (Figure 2A, Additional file 1).
The largest statistically significant fold-changes were
observed in Duox1, Prx1, Grx2, and SOD1 mRNA levels
(p < 0.05). We attribute these large changes (> ± 50%)
in the redox regulatory network to a response to the
cellular stress caused by viral integration into the gen-
ome. Minor but statistically significant changes of ± 20-
50% were observed in mRNA of Prx4, Rac2, Ref1, IDH2,
and CAT. All further references to the knockdown cell
lines will be with respect to the pLKO control cells
unless explicitly stated.
The three silenced cell lines showed common non-
specific effects as well as more target-specific variation
as measured by qRT PCR. Surprisingly, silencing Trx1,
Grx1, and G6PD each led to statistically significant
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Page 2 of 13decreases in Prx2 mRNA levels (11%, 35%, 13% expres-
sion, respectively). The Trx1 and Grx1 silenced cells
also showed common reduction in sulfiredoxin 1 (Srx1)
mRNA levels, while the Grx1- and G6PD-silenced cells
both experienced reduced levels of Duox1 mRNA. The
Grx1-silenced cells showed the most widespread off-tar-
get changes with respect to the control cells, with
mRNA levels of 8 additional proteins affected: Prx4,
IDH2, Ref1, Rac2, CAT, SOD2, G6PD, Trx2 (Figure 2B,
C, Additional File 1).
In order to better determine what portion of the
observed changes in mRNA levels was due to off-target
effects of the shRNA and what portion could be attribu-
ted to lentiviral infection, we also compared the pLKO
and shRNA cells to wild-type Jurkat cells (Additional
File 1). With the exception of Prx2 for Trx1 and G6PD
shRNA cells and Duox1 for G6PD shRNA cells, none of
the significant changes in mRNA levels in our shRNA
cells as compared to pLKO were accompanied by a
similar change in mRNA levels in shRNA and pLKO
cells when compared to wild-type cells.
In order to determine whether the measured changes
in mRNA levels detected in our array reflected true
changes in protein expression, each cell line was further
assayed by western blot for Duox1 and Prx2 protein
levels. These proteins could be further investigated
because decreased levels of silencing were diverse
enough in all three shRNA targets to create a broad
range of values. As shown in Figure 3, the mRNA levels
strongly correlated to protein levels for Duox1 (R
2 =
0.79), while the relation was stronger for Prx2 (R
2 =
0.91). Because the wild-type, uninfected cells repre-
sented an additional independent point to relate mRNA
to protein, this measurement was included in the
regression.
Evaluation of co-variance among redox enzymes
To evaluate patterns of co-variance among the mRNA
levels, we modeled the array data by principal compo-
nent analysis. This statistical modeling method, which
collapses multivariate data into reduced dimensions, is
useful for extracting patterns of co-variance across mul-
tiple observations. We created a data matrix consisting
of five independent cell line observations: wild-type Jur-
k a tc e l l s ,p L K Ov e c t o rc o n t r o l ,G r x 1s h R N A ,T r x 1
shRNA and G6PD shRNA. Two principal components,
or latent variables, were sufficient to explain 77.5% of
the data variance, with PC1 capturing 44.4% and PC2
capturing 34.1%. The loadings plot as shown in Figure
4A illustrates relationships between genes. For example,
the Trx2 and Ref1 mRNA levels are most tightly related
among all variables as visualized by Euclidean distance.
Some protein isoforms, such as the isocitrate dehydro-
genases (IDH1, IDH2) map similarly in their contribu-
tion to the model. Likewise, the clustering of
peroxiredoxin isoforms in the second principal compo-
nent indicates that these proteins similarly contribute to
the overall variance of the dataset, and likely reflect
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Figure 1 Characterization of shRNA cell lines.( A )b-Actin
normalized mRNA levels of target silencing in selected cell lines
with respect to pLKO. (B) Expression levels of target protein after
stable shRNA silencing of Grx1, Trx1, and G6PD in Jurkat cells
compared to pLKO empty vector control. Selected shRNA sequence
is denoted with asterisk. (C) Growth curves of selected stable
knockdown cell lines show changes in cell proliferation rates
between shRNA and control cells. Error bars represent ± standard
error (n = 3).
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Page 3 of 13coordinated up- and down-regulation across the cell
lines. Other isoform pairs (Trx1/Trx2 and SOD1/SOD2)
show little co-variance and instead suggest insularity
between mitochondrial and cytosol-specific proteins.
Principal component analysis also highlights anticorrela-
tive relationships by locations in opposing quadrants. In
contrast to the IDH and Prx proteins, other isoforms
have anticorrelative relationships, suggesting a compen-
satory effect in which cells up-regulate one gene to pro-
tect against the down-regulation of another. Protein
pairs that fall within this category include Duox1/Duox2
and Nox1/Nox5.
Having established that our library of cell lines exhib-
ited variation in both Prx2 mRNA and protein levels in
response to the silencing of a variety of components
within the redox regulatory network, we next asked if it
was possible to modulate non-specific protein levels by
shRNA-induced gradations in one of the redox couples.
From the principal component analysis (Figure 4A), we
predicted that Grx1 and Prx2 would strongly co-vary in
levels. Three additional Grx1 shRNA stable cell lines
ranging in efficiency from 20 to 65% knockdown levels
were probed for Grx1 and Prx1, as was the wild-type
cell line. We found that the Prx2 protein levels were co-
Table 1 PCR array target list
Gene
Symbol
Alias Accession
#
Official Full Name
CAT MGC138422/MGC138424 NM_001752 Catalase
GPX1 GSHPX1/MGC14399/MGC88245 NM_000581 Glutathione peroxidase 1
GSR MGC78522 NM_000637 Glutathione reductase
PRDX1 MSP23/NKEFA/PAG/PAGA/PAGB/PRX1/PRXI/
TDPX2
NM_002574 Peroxiredoxin 1
PRDX2 MGC4104/NKEFB/PRP/PRX2/PRXII/TDPX1/TSA NM_005809 Peroxiredoxin 2
PRDX4 AOE37-2/PRX-4 NM_006406 Peroxiredoxin 4
APEX1 APE/APE1/APEN/APEX/APX/HAP1/REF1 NM_080649 APEX nuclease (multifunctional DNA repair enzyme) 1
SRXN1 C20orf139/Npn3/SRX1/YKL086W/dJ850E9.2 NM_080725 Sulfiredoxin 1 homolog (S. cerevisiae)
TXNRD1 GRIM-12/MGC9145/TR/TR1/TRXR1/TXNR NM_003330 Thioredoxin reductase 1
GLRX GRX/GRX1/MGC117407 NM_002064 Glutaredoxin (thioltransferase)
GLRX2 GRX2/bA101E13.1 NM_197962 Glutaredoxin 2
TXN DKFZp686B1993/MGC61975/TRX/TRX1 NM_003329 Thioredoxin
TXN2 MT-TRX/MTRX/TRX2 NM_012473 Thioredoxin 2
G6PD G6PD1 NM_000402 Glucose-6-phosphate dehydrogenase
IDH1 IDCD/IDH/IDP/IDPC/PICD NM_005896 Isocitrate dehydrogenase 1 (NADP+), soluble
IDH2 ICD-M/IDH/IDHM/IDP/IDPM/mNADP-IDH NM_002168 Isocitrate dehydrogenase 2 (NADP+), mitochondrial
AQP8 - NM_001169 Aquaporin 8
DUOX1 LNOX1/MGC138840/MGC138841/NOXEF1/
THOX1
NM_175940 Dual oxidase 1
DUOX2 LNOX2/NOXEF2/P138TOX/THOX2 NM_014080 Dual oxidase 2
NOX1 GP91-2/MOX1/NOH-1/NOH1 NM_007052 NADPH oxidase 1
CYBB CGD/GP91-1/GP91PHOX/GP91PHOX/NOX2/
p91-PHOX
NM_000397 Cytochrome b-245, beta polypeptide
NOX3 GP91-3 NM_015718 NADPH oxidase 3
NOX4 KOX/KOX-1/RENOX NM_016931 NADPH oxidase 4
NOX5 MGC149776/MGC149777/NOX5A/NOX5B NM_024505 NADPH oxidase, EF-hand calcium binding domain 5
RAC1 MGC111543/MIG5/TC-25/p21-Rac1 NM_006908 Ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding
protein Rac1)
RAC2 EN-7/Gx/HSPC022 NM_002872 Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding
protein Rac2)
SOD1 ALS/ALS1/IPOA/SOD/homodimer NM_000454 Superoxide dismutase 1, soluble
SOD2 IPO-B/MNSOD/Mn-SOD NM_000636 Superoxide dismutase 2, mitochondrial
ACTB PS1TP5BP1 NM_001101 Actin, beta
The official full names, gene symbols, aliases, and accession numbers for the mRNA targets included in the PCR array.
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Page 4 of 13expressed with Grx1 in three of our four cell lines (Fig-
ure 4B).
Cellular responses to oxidative stress
Because our results suggested that the shRNA cells pos-
sess a reduced capacity to handle oxidative insult, we
tested the functional consequences of a perturbed redox
couple in the presence of a bolus addition of 100 μM
hydrogen peroxide. Previously, a computational model
of cellular hydrogen peroxide clearance was developed
and optimized for wild-type Jurkat cells [1]. Built pri-
marily using mass action kinetics, this model is the
most comprehensive to date for examining the relative
contributions of the peroxiredoxin system, protein S-
thiolation, catalase, and glutathione/glutathione peroxi-
dase mechanisms for removing hydrogen peroxide from
the intracellular cytosolic environment. The model is
accurate for up to one hour of dynamic simulation post-
addition of an exogenous bolus of hydrogen peroxide
ranging from 0-100 μM and is capable of explaining the
independence in timescales of the thioredoxin and
glutathione redox couples. To make the model compati-
ble with the enzymatic changes associated with lentiviral
entry, parameters and initial conditions associated with
the genes that had statistically significant differences by
mRNA changes (p < 0.05) between the pLKO cell lines
and each of the other cell lines (Figure 2) were altered
(Table 2) to generate cell line-specific models. These
models did not take into account possible changes in
glutathione and NADPH content, nor potential post-
translational alterations to proteins that could result
from an altered basal redox status. Furthermore, as the
model assumes a well-mixed compartment, it is incap-
able of describing the enzymatic production of H2O2
that would occur due to NADPH oxidases.
We compared the simulations of these models in
response to a 100 μM bolus treatment of hydrogen per-
oxide to the idealized case of perfect, specific targeting.
These simulations were conducted to determine the
effect of off-target alterations on the intracellular redox
buffering capacity of the knockdown cell lines. Results
of this analysis reveal that the off-target alterations
Ϳ Ϳ
Ϳ
Figure 2 Variability of non-target redox enzymes. (A) Changes in off-target expression levels for wild-type Jurkat cells relative to pLKO empty
vector control cells. Genes with significantly altered mRNA levels are colored green. (B) Changes in off-target expression levels for Grx1 shRNA
(blue, circles), Trx1 shRNA (red, diamonds) and G6PD shRNA (orange, triangles), relative to pLKO control. (C) Venn diagram of significant gene
changes. Statistical significance for all plots based upon p < 0.05.
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Page 5 of 13caused by the introduction of pLKO shRNA, Trx1
shRNA, and G6PD shRNA lentiviral particles do not
result in significant changes to the intracellular redox
buffering capacity of the respective knockdown cell
lines (Figure 5). However, the off-target alterations that
result from Grx1 shRNA targeting result in significant
alterations to the intracellular redox buffering capacity
of the Grx1 knockdown cells (Figure 5). Upon further
analysis of the off-target proteins that are affected by
each of the shRNA constructs, it was discovered that
the Grx1 shRNA lentiviral particle was the only lenti-
viral particle whose cellular introduction resulted in
the off-target alteration of the G6PD enzyme. Based on
this finding, we hypothesized that the off-target altera-
tion of the G6PD enzyme was the primary additional
modulation that was responsible for the significant dif-
ferences seen between the ideal Grx1 knockdown
behavior and the Grx1 knockdown behavior in the pre-
sence of off-target effects. To test this possibility, we
simulated the hypothetical redox behavior of the Grx1
knockdown cell line without any off-target effects (i.e.
idealized case) and with all off-target effects except for
t h o s ei n v o l v i n gt h eG 6 P De n z y m e( F i g u r e6 ) .T h e s e
simulations suggest that if G6PD is not an off-target of
Grx1 shRNA, then the Grx1 knockdown cells with off-
target alterations should have the same redox buffering
capacity in the presence of exogenous peroxide addi-
tion as the ideal Grx1 knockdown cells with no off-tar-
get alterations.
To establish the possible synergy of altered Grx1 and
altered G6PD as drivers of redox state, we simulated
conditions where only these two proteins are altered in
the redox network versus all off-target effects except
G6PD (Figure 6). Inclusion of the other Grx1 shRNA
off-target proteins closely mimics the “idealized” case of
just Grx1 silencing. In contrast, simulations of the Grx1
shRNA silencing solely in the presence of off-targeted
reduction of G6PD dramatically influences the system
behavior. This further indicates that the loss of robust-
ness in redox capacity is due to a combined effect of
Grx1 and G6PD.
Discussion
Perturbations of cellular redox couples are instructive in
applications that investigate the mechanisms of thiol-
based signaling, protection from inflammatory reactive
oxygen species and the metabolism of cysteines. Use of
small molecule inhibitors such as carmustine (inhibitor
of glutathione reductase) or dehydroepiandrosterone
(inhibitor of G6PD) provide rapid alterations in the
behavior of the redox enzymatic network, but this is
potentially at the expense of specificity. Alternatively,
small interfering RNA (siRNA) can transiently reduce
protein levels with a high degree of specificity, but cellu-
lar characterization of the induced changes is often lim-
ited by the viability and transduction efficiency of the
cells under investigation. Lentiviral infection of shRNA
is purported to address both specificity and cell number
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Figure 3 Correlation between protein and mRNA levels. Representative blots showing variation in (A) Prx2 and (B) Duox1 protein levels due
to off-target effects of lentiviral shRNA. Correlation between protein levels derived from these blots and mRNA level for (C) Prx2 and (D) Duox1
in shRNA cell lines and wild type Jurkat cells.
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Page 6 of 13limitations through the selection for stable incorporation
of the interfering RNA within the genome. An addi-
tional benefit of stable silencing is the ability to assess
long-term changes in the expression levels of other
genes in response to the target. These changes take
place on time-scales that vary among individual pro-
teins; for example, in a genome-wide study of mouse
embryonic stem cells, mRNA of NAD(P)H oxidase iso-
forms decay with half-lives on the order of 4-5 hours,
while peroxiredoxins 1 & 2 and isocitrate dehydrogenase
1 & 2 had half-lives of 20-24 hours [25]. Consequently,
when accounting for changes in mRNA and protein
decay rates and sequential feedback, cellular remodeling
in response to a silenced redox protein may not be fully
implemented across all proteins to a new homeostatic
state for several days. All of the shRNA cell lines used
for this study had undergone at least three passages
from the lentiviral infection and puromycin selection
before characterization.
Because of the advantages to using shRNA, this
method of examining redox regulation of cellular pro-
cesses has been increasingly used to study effects of
NAD(P)H supply, glutaredoxin, thioredoxin, and asso-
ciated reductases [16-22]. Many of these studies rely on
perturbation of the target protein in order to observe a
phenotypic change, such as sensitivity to diamide-
induced oxidative stress [19] or increased cellular senes-
cence [22], and rely on the assumption that the rest of
the antioxidant enzyme system remains intact. Our
results, however, question this assumption by the
changes observed in both the empty lentiviral construct
and off-target changes due to specific protein silencing.
We measured dramatic changes in redox protein mRNA
levels due to the presence of the empty lentiviral vector,
compared to uninfected cells. This is consistent with a
vector-independent interferon response that is initiated
by shRNA [26] or altered regulation of autocrine cyto-
kines [27]. Furthermore, interferon g stimulated
response elements (ISRE) have been identified in the
promoter regions of Nox1 and Nox2 [28,29] and there-
fore may potentially also control expression levels of
other proteins involved in regulation of ROS, such as
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Table 2 Cell-line specific parameter sets for computational modeling
Initial condition/rate constant Jurkat pLKO Grx1 shRNA Trx1 shRNA G6PD shRNA
Grx1-SH (μM) 1.2 1.2 0.62 1.2 1.2
Trx1ox + Trx1red (μM) 0.505 0.505 0.505 0.144 0.505
G6PD (M⋅s
-1) 3.75e-4 3.75e-4 2.55e-4 3.75e-4 1.24e-4
Prx2-SH2 (μM) 19.2 19.2 12.5 17.1 16.7
Srx1 (s
-1) 3e-3 3e-3 1.74e-3 1.95e-3 3e-3
CAT (μM) 0.9 1.17 0.8 0.9 0.9
Numbers in bold represent altered parameters from the wild-type Jurkat cell line.
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characterized shRNA cell lines with qRT PCR-determined off-target effects (pLKO, Grx1*, Trx1*, G6PD*).
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Page 8 of 13Duox1 and Rac1. Grx1 has been reported to be an
essential regulator of interferon response factor-3 in
Sendai virus infected cells [30]; if this role is conserved
in all lentiviral infection, this mechanism may partially
account for the sensitivity of the Jurkat cells to Grx1-
specific RNA interference. Phosphorylation of the a
subunit of eukaryotic initiation factor 2 (eIF2) through
protein kinase R (PKR) is induced by IFN-g and TNF-a
[31,32] as well as a variety of stress conditions, including
viral infection, and has been shown to down-regulate
protein synthesis [33,34]. Therefore, lentiviral infection
could potentially have post-translational effects on eIF2-
a, thereby altering the regulation of protein synthesis. It
should also be noted that treatment with aminoglycoside
antibiotics has been shown to have effects on the
expression levels of Grx1, and oxidative stress induced
by antibiotics should be included as a potential cause
for the changes we observed [35]. We have taken this
into account in our experiments by using a control cell
line (pLKO vector cells) that was cultured in the same
puromycin-containing media as our shRNA cells. We
compared our shRNA cells to this cell line and also
compared mRNA levels in our shRNA and pLKO cell
lines to that of wild-type cells (Figure 2, Additional file
1); however, a direct comparison of the effects of puro-
mycin was not feasible, as puromycin was toxic to our
wild-type cells.
In past cDNA microarray studies of responses asso-
ciated with oxidative stress, transcriptional changes are
reported as up- or down-regulated expression levels
rather than the coordinated regulation of the redox-
related enzymes [36-39]. Prior microarray studies on
virally-infected T cells have not reported significant
changes across the antioxidant enzyme network as
observed in the present analysis, instead yielding one or
two redox-related genes in the genomic arrays [40,41].
In contrast, other studies have demonstrated careful
characterization of antioxidant enzyme changes, but
only on a select few proteins (e.g. [42]). Systematic his-
tological characterization of redox protein distribution
provides complementary information, but does not
allow for direct multivariate expression relationships on
a large scale [43]. The intent of this study was to pro-
vide a more targeted approach with proteins that coor-
dinate H2O2 production and clearance from the
intracellular environment while still monitoring enough
genes to observe systemic effects. Microarray and qRT
PCR results may not always directly correspond to pro-
tein levels; however for a subset of proteins character-
ized in the present data (Grx1, Trx1, G6PD, Prx2, and
Duox1) a linear relationship between mRNA and pro-
tein levels was observed.
Peroxiredoxins have emerged as important regulators
of cellular redox status [1,44]. Among the coupled
reactions of peroxiredoxin, thioredoxin, and sulfiredoxin,
our network approach yielded novel insight into the reg-
ulation of this enzyme family (Figure 4A). A strong co-
expression pattern emerged between the three peroxire-
doxins measured (Prx1, 2, 4). Thioredoxin reductase
also tightly co-varied with the peroxiredoxins while
Trx1 showed less relation. A direct correlation between
Srx1 and the rest of the peroxiredoxin branch was not
established across the cell lines assayed, but the Trx1
knockdown cells showed a significant decrease in Srx1
(35%, p < 0.05). The off-target Srx1 compensation
caused by attenuation of thioredoxin 1 expression may
be more tightly regulated than our analysis suggests and
could be explored further by epi-allelic strains of Trx1
shRNA targets. The distance between Prx2 and Grx1 in
the principal component analysis demonstrated a stron-
ger expression regulation between these two proteins
than with Srx1 or Trx1. Because glutaredoxin 1 is not a
substrate for the peroxiredoxins [45], this trend was
unexpected but it was supported by analysis with addi-
tional cell lines. It has been postulated by Winterbourn
and Hampton that additional functionality of peroxire-
doxins through facilitated, indirect oxidation of other
proteins could provide an alternate method of oxidative
signal transmission [46]; if protein sulfenic acid is gener-
ated in this manner and subsequently protected by S-
glutathionylation, than coordination between peroxire-
doxins and Grx1 expression would be appropriate.
Disequilibrium of redox couples between the cyto-
plasm, ER, mitochondria, and nuclei has been elucidated
through investigations of the differential subcellular sen-
sitivities to oxidative stress [2,47-54]. The nature of the
oxidative stress preferentially impacts different locations
[55]; for example, EGF signaling induces Trx1 oxidation
[51], while Trx2 is preferentially oxidized with TNF-a
treatment [56]. The co-varying relationships and expres-
sion patterns illustrated in Figure 4A indicate that this
insularity extends to a lack of up-regulated compensa-
tion of alternate isoforms when a cytosolic component
(Trx1, Grx1) is altered, as we observed no statistical dif-
ferences in the corresponding mitochondrial Trx2 and
Grx2. In contrast, the computational modeling results
suggest changes in the cytosolic NAD(P)H supply by
G6PD silencing may result in enhanced mitochondrial
NAD(P)H production by a dehydrogenase, IDH2. A sig-
nificant decrease (35%, p < 0.05) in Trx2 upon Grx1
silencing was detected, however, but no known mechan-
ism for communication between these compartmenta-
lized redox proteins is known.
Changes due to the presence of the lentivirus could be
accounted for with proper control experiments if not for
the added non-specific off-target effects resulting from
manipulating the various redox couples through RNA
interference. The shRNA sequences used in the present
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Page 9 of 13study were for disparate protein targets with unique
sequences, thus the changes observed are attributed to
compensation by the cell for decreased reducing capabil-
ities rather than direct silencing by RNA interference.
Computational analysis allowed for the direct compari-
son of the idealized shRNA specificity to the more likely
behavior if changes in mRNA levels reflect changes in
protein translation. Although all the cell lines with lenti-
virus except the Grx1 shRNA knockdown cell line
showed insignificant differences in antioxidant capacity
d u et oo f f - t a r g e te f f e c t s ,i ts h o u l db en o t e dt h a tn o ta l l
the off-target effects detected by qRT PCR were capable
of being simulated using the current cytosolic model.
For example, downregulation of oxidative enzymes such
as the Nox/Duox family, which would likely impact sig-
naling-induced antioxidative responses, is not reflected
in the models. This feature of ROS production is miss-
ing as the computational description only accounts for
the dissipation of H2O2 by permeation through the cell
membrane and clearance by glutathione, peroxisomes,
and cytosolic enzymatic reactions. Our data shows that
Duox1 was significantly downregulated in both the Grx1
and G6PD shRNA cell lines. It is possible that a more
comprehensive model, one which is spatially descriptive
and includes mitochondrial and membrane related anti-
oxidant enzymes, could more readily show the resulting
effect of off-target alterations on cellular antioxidant
capacity. However, with the current modeling analysis, it
is clear that off-target effects involving the G6PD
enzyme system are more likely to result in significant
changes in the overall redox capacity of the cell, com-
pared to the idealized knockdown condition.
A caveat of our simulations is the numerous metabolic
and post-translational modifications that are likely
occurring in the cell lines. Although we maintained uni-
form redox state of NADPH/NADP
+,T r x 1 - S H 2/Trx1-
SS, and GSH/GSSG for each cell-line specific model,
each of these may be altered in response to the lentiviral
constructs. For instance, G6PD knockdowns cells have
been shown to exhibit an impaired ability to regenerate
GSH [17]. Another caveat is that we have assumed that
changes in mRNA levels will be reflected in protein
levels. Although our detailed analysis of two proteins
did show a linear correlation between mRNA and pro-
tein (Figure 3), this relation may not be upheld for all
proteins due to translational regulation. Furthermore,
proteins beyond the scope of our array involved in
transport and metabolite synthesis may be altered to
control the total available pools of NADPH and glu-
tathione. Our analysis, therefore, is useful strictly as a
means of examining one aspect of redox remodeling
associated with viral infection and shRNA.
A surprising finding of our experimental and compu-
tational work is the dichotomy between the numerous
changes that result at the mRNA level due to the intro-
duction of lentiviral mRNA and the minor possible
functional consequences in the overall ability of cells to
handle acute, exogenous oxidative insult. Our shRNA
perturbations of each redox couple indicated sensitivity
to protein levels that were apparent only by inspection
of multiple metrics of oxidative stress (Figure 5). With
the exception of the Grx1/G6PD relationship, the off-
target effects largely did not influence functionality of
the redox enzymatic network as tested by our simula-
tions. These results need to be investigated experimen-
tally; for example, future studies of combined targeted
silencing of both genes could characterize the necessary
ratios of each protein required to maintain a robust
redox system. Additional experiments are also necessary
to establish whether the concomitant downregulation of
ROS producing enzymes and enzymes involved in ROS
scavenging is reflected in an increased resistance to cel-
lular oxidation required for many signal transduction
processes.
Conclusions
In conclusion, this systemic study of gene co-regulation
upholds findings of biochemical network analyses
[1,57,58], namely that global cellular antioxidant capa-
city is a finely-tuned balance of multiple redox reactions
tightly interconnected through common NAD(P)H sup-
ply, requiring systems-level characterization of reversible
thiol oxidation. RNA interference provides a method to
directly manipulate components of the pertinent oxida-
tion and reduction enzymes where small molecule inhi-
bitors are unavailable, but at a cost of unintentionally
altering other aspects of the network. Attenuation of
oxidases and associated regulatory components is one
way that cells adjust to a perturbed antioxidant capacity.
Computational approaches such as principal component
analysis harness the unintended off-target effects in
order to glean insight into compensatory measures that
cells utilize as protection against oxidative damage; how-
ever our analysis points to challenges that can arise in
implementing cell line-specific dynamic models if all
non-specific effects are not built into the new parameter
sets. While the application in the present study was
RNAi-induced changes, this methodology of analysis
would be useful in studying other forms of chronic
reductive or oxidative stress.
Methods
Cell culture
Jurkat cells (ATCC, Manassas, VA) were cultured in
RPMI-1640 medium (Sigma-Aldrich, St Louis, MO) sup-
plemented with 10% FBS, 1% HEPES, 1% MEM non-
essential amino acids, 1% sodium pyruvate, 100 U/ml
penicillin, and 100 μg/ml streptomycin. Knockdown
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tion of 4 μg/ml puromycin. Cells were cultured at a
density of between 0.2 and 1.5 × 10
6 cells/ml in a humi-
dified atmosphere of 5% CO2 and 95% air at 37°C. For
proliferation studies, cell density was calculated by
hemocytometer every 24 hours.
RNA interference
Stable knockdowns were created from Jurkat cells by
targeting the expression levels of Grx1, Trx1 or G6PD,
using MISSION Lentiviral shRNA Transduction Parti-
cles (Sigma-Aldrich) according to manufacturer’s proto-
col with puromycin selection (4 μg/ml). Jurkat cells with
empty pLKO.1-puro lentiviral plasmid were used as con-
trol cells. MISSION TurboGFP™ Control Transduction
Particles (Sigma-Aldrich) were used in a parallel experi-
ment as a control for transduction efficiency.
qRT PCR
RNA was isolated from cells using the RNeasy isolation
kit (SABiosciences, Frederick, MD) with RNase-free
DNase set (Qiagen, Valencia, CA) according to the man-
ufacturer’sp r o t o c o l .1μg of RNA was used for reverse
transcription. The reverse transcription reactions were
performed using the SuperScript III First-Strand Synth-
esis System (Qiagen) for Trx1 shRNA validation and the
RT2 first Strand Synthesis Kit (SABiosciences) for Grx1
shRNA validation and PCR array. Both kits were used
according to manufacturer’s protocol.
For shRNA validation, qRT PCR was run using pri-
mers for human Grx1, Trx1, and G6PD (SABiosciences).
For detection of other mRNA levels, a custom RT2 Pro-
filer PCR Array (SABiosciences) was used, according to
manufacturer’s protocol. A list of targets included in the
array can be found in Table 1. PCR conditions were as
follows: 10 min at 95°C; 40 cycles of 1 minute at 60°C
and 15 seconds at 95°C; melt curve with ramp from 60°
C to 95°C. All PCR reactions were run using the Step
One Plus system (Applied Biosystems, Carlsbad, CA).
Results were normalized to the expression of b-actin.
Relative expression levels were calculated using the ΔCT
method (2
-ΔCT). All arrays were performed with tripli-
cate sets of RNA isolation for each cell line for statistical
analysis.
Cell lysis for western blotting
For western blotting, 8 × 10
6 cells were lysed in 200 μl
lysis buffer buffer containing 2% NP-40, 50 mM b-gly-
cerophosphate, 10 mM NaP, 30 mM NaF, 50 mM Tris,
pH 7.5, 150 mM NaCl, 1 mM benzamidine, 2 mM
EGTA, 100 μM sodium orthovanadate, 1 mM DTT, 10
μg/ml aprotinin, 10 μg/ml leupeptin, 1 μg/ml pepstatin,
1 μg/ml microcystin-LR, and 1 mM PMSF. Cells were
lysed on ice for one hour, followed by centrifugation for
10 minutes at 14000 rpm. Protein concentration was
determined with the Micro BCA™ Assay Kit (Thermo-
Fisher Scientific, Waltham, MA). For ΔPr-SSG blots,
cells were lysed in a non- reducing buffer containing 2%
NP-40, 50 mM Tris, pH 7.5, 150 mM NaCl, 1 mM ben-
zamidine, 2 mM EGTA, 10 μg/ml aprotinin, 10 μg/ml
leupeptin, 1 μg/ml pepstatin, 20 mM ethylmaleimide,
and 1 mM PMSF.
Western blotting
For western blots, 20 to 40 μg of total protein/sample
was subjected to SDS-PAGE and transferred to PVDF
membranes. For Pr-SSG blots, this was done under
non-reducing conditions. The membrane was blocked
with Near Infra-Red Blocking Buffer (Rockland Immu-
nochemicals, Gilbertsville, PA) at room temperature for
1 hour. Primary antibodies were used at a dilution of
1:1000 in 10 ml blocking buffer and incubated over
night at 4°C, followed by three washes in TBS-T. Sec-
ondary antibodies (IR dye 680CW donkey anti-mouse,
IR dye 800CW anti-goat or IR dye 800CW donkey anti-
rabbit, all from LI-COR Biosciences (Lincoln, NE), were
all used at a dilution of 1:15000 in 10 ml blocking buffer
and incubated for 1h at room temperature. This was fol-
lowed by two washes in TBS-T and one wash in TBS.
Imaging and image analysis were done using the Li-Cor
Odyssey Infrared Imaging System with the Odyssey 2.1
software. b-actin was used as loading control. Primary
antibody for Grx1 was purchased from R&D Systems
(Minneapolis, MN), for full length Trx1 from BD Bios-
ciences (Franklin Lakes, NJ), for Duox1 from Novus Bio-
logicals (Littleton, CO), for Prx1 from Millipore, for
Prx2 from Abcam (Cambridge, MA), for glutathione
from Virogen (Watertown, MA), and for b-actin from
Sigma-Aldrich.
Statistical analysis
All values reported are the average of three independent
biological replicates +/- standard error. Statistical signifi-
cance is based upon the criteria of p < 0.05 for a Stu-
dent’s t-test (two-tailed, equal variance). Principal
component analysis was performed by first mean center-
ing and unit variance scaling the 2
ΔCt values (normalized
to b-actin) to create a 5 × 28 data matrix. Simca-P soft-
ware (Umetrics, Umeå, Sweden) provided stringency
tests for determining the minimum number of latent
variables (components) necessary to capture covariance
in the data.
Modeling simulations
A previously published model of the redox regulatory
network was originally developed and optimized for
wild-type Jurkat parameters [1]. This model was capable
of simulating the clearance of 100 mM exogenous
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cell density of 10
6 cells/mL. A fundamental feature of
the kinetic description is the use of changes in species
from baseline instead of absolute concentrations due to
the inherent disequilibrium in redox couples [2]. For the
simulations presented here, all model parameters and
files are identical to those in [1] except where noted
below, and the kinetic equations can be found in Addi-
tional File 2. The model was adjusted to new baseline
v a l u e sf o rt h ep L K O ,G r x 1s h R N A ,T r x 1s h R N A ,a n d
G6PD shRNA by calculating the fold change for statisti-
cally significant differences (p < 0.05) in RNA levels of
the following genes as described in Table 2: Prx2,
G6PD, Grx1, Trx1, CAT, and Srx1. Changes to alternate
isoforms of these genes (e.g Prx1, Prx4, Grx2, Trx2)
were not factored into the model simulations in Figures
5 &6. The components that are represented in the
model as species had their total concentrations adjusted
accordingly. The components whose levels were impli-
citly reflected in a rate constant (G6PD, Srx1) had a
fold-change alteration in parameter value. For the idea-
lized cases, only the target of interest (Grx1, Trx1, and
G6PD, respectively) was altered according to the altered
mRNA value. Simulations of 60 minute responses were
performed using Matlab 7.9.0 r2009b.
Additional material
Additional file 1: Significant changes in mRNA expression levels in
shRNA and pLKO cells lines. Significant changes (p < 0.05) in mRNA
expression levels in shRNA cell lines and pLKO control cells compared to
wild-type Jurkat cells, and in shRNA cells and wild-type cells compared
to pLKO cells. Names in black represent targets that were expressed in all
five of our cells lines, while names in red represent mRNA targets that
were not expressed (Ct ≥ 35) in any of our cells lines.
Additional file 2: Description of computational model used for
simulations in figures 5and 6. Further details of model description and
sources for parameter values can be found in Adimora NJ, Jones DP,
Kemp ML. “A model of redox kinetics implicates the thiol proteome in
cellular hydrogen peroxide responses.” Antioxid Redox Signal 2010,
13:731-743. Each cell line represented in the simulations was modified by
adjusting the subset of parameters listed in Table 2 of the main text.
List of abbreviations
G6PD: glucose-6-phosphate dehydrogenase; GSH: reduced glutathione;
GSSG: glutathione disulfide; IDH: isocitrate dehydrogenase; IoM: ionomycin;
Grx: glutaredoxin; NAD(P)H: nicotinamide adenine dinucleotide phosphate;
RNAi: RNA interference; PMA: phorbol-12-myristate-13-acetate; Prx:
peroxiredoxin; ROS: reactive oxygen species; shRNA: short interfering RNA;
siRNA: small interfering RNA; Srx: sulfiredoxin 1; Trx: thioredoxin
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